Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Novospray** is an investigational, locally administered artificial-saliva oral spray developed at the Academic Centre for Dentistry Amsterdam for symptomatic relief of xerostomia, including dry mouth associated with Sjögren's syndrome. It was evaluated in a randomized crossover study against a placebo spray. The publicly available trial materials describe the investigational artificial-saliva spray as containing an ingredient derived from chicken eggs, but do not publicly identify its complete composition or a defined molecular target. Its intended action is physical and symptomatic: supplementing oral moisture and improving oral comfort rather than restoring salivary-gland function or modifying the autoimmune pathology of Sjögren's syndrome. ([onderzoekmetmensen.nl](https://onderzoekmetmensen.nl/en/node/20248/pdf))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Novospray.